| 000 | 01333 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518072231.0 | ||
| 264 | 0 | _c20200928 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1607-842X | ||
| 024 | 7 |
_a10.1080/08916934.2019.1693545 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuhammad Yusoff, Farhana | |
| 245 | 0 | 0 |
_aTh1, Th2, and Th17 cytokines in systemic lupus erythematosus. _h[electronic resource] |
| 260 |
_bAutoimmunity _c02 2020 |
||
| 300 |
_a8-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAutoimmune Diseases _ximmunology |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aTh1 Cells _xdrug effects |
| 650 | 0 | 4 |
_aTh17 Cells _xdrug effects |
| 650 | 0 | 4 |
_aTh2 Cells _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWong, Kah Keng | |
| 700 | 1 | _aMohd Redzwan, Norhanani | |
| 773 | 0 |
_tAutoimmunity _gvol. 53 _gno. 1 _gp. 8-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/08916934.2019.1693545 _zAvailable from publisher's website |
| 999 |
_c30356096 _d30356096 |
||